TEGOPEN INJ 250MG/VIAL DIN 00407593
Status: Cancelled Post Market
Holder: BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
Molecule: CLOXACILLIN SODIUM
Health Canada record
| Active ingredient(s) | CLOXACILLIN SODIUM 250 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CF02 CLOXACILLIN |
| Original market date | 31-Dec-1973 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOXACILLIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00618292 | APO CLOXI CAP 250MG | APOTEX INC | Capsule | CLOXACILLIN SODIUM 250 MG | Cancelled Post Market |
| 00618284 | APO CLOXI CAP 500MG | APOTEX INC | Capsule | CLOXACILLIN SODIUM 500 MG | Cancelled Post Market |
| 00644633 | APO CLOXI FOR ORAL SOLN 125MG/5ML | APOTEX INC | Powder For Solution | CLOXACILLIN SODIUM 125 MG | Cancelled Post Market |
| 01975447 | CLOXACILLIN SODIUM FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | CLOXACILLIN SODIUM 1 G | Cancelled Post Market |
| 01912410 | CLOXACILLIN SODIUM FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | CLOXACILLIN SODIUM 2 G | Cancelled Post Market |
| 01912429 | CLOXACILLIN SODIUM FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | CLOXACILLIN SODIUM 500 MG | Cancelled Post Market |
| 00002046 | ORBENIN CAP 250MG | AYERST LABORATORIES | Capsule | CLOXACILLIN SODIUM 250 MG | Cancelled Post Market |
| 00002054 | ORBENIN CAP 500MG | AYERST LABORATORIES | Capsule | CLOXACILLIN SODIUM 500 MG | Cancelled Post Market |
| 00002186 | ORBENIN INJ 2000MG | AYERST LABORATORIES | Powder For Solution | CLOXACILLIN SODIUM 2 G | Cancelled Post Market |
| 00002151 | ORBENIN INJ 250MG | AYERST LABORATORIES | Powder For Solution | CLOXACILLIN SODIUM 250 MG | Cancelled Post Market |
| 00002445 | ORBENIN PWR 125MG/5ML | AYERST LABORATORIES | Powder For Solution | CLOXACILLIN SODIUM 125 MG | Cancelled Post Market |
International API supply for CLOXACILLIN SODIUM
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for TEGOPEN INJ 250MG/VIAL